Please enable JavaScript.
Coggle requires JavaScript to display documents.
The Role of Cardio-oncologists - Coggle Diagram
The Role of Cardio-oncologists
Cardiovascular Complications
of Cancer Treatment
myocardial
dysfunction and heart failure
complications
of cancer therapy
is associated with
a broad spectrum of anticancer treatment
Nine categories
valvular disease
arrhythmias
coronary
artery disease
QT-prolonging
myocardial dysfunction and heart failure
arterial hypertension
thromboembolic disease
peripheral vascular disease and stroke
pulmonary hypertension and
pericardial complications
Detection
ECG
blood pressure monitoring
imaging methods
biomarker
testing
coronary arteriography
cardiac catheterization
Patients
Treated with Potentially Cardiotoxic Drugs
factors for CV risk
previous cardiotoxic
cancer treatment
demographic risk factors
current myocardial disease
life-style risk factors
asymptomatic patients
with significantly decreased ejection fraction
the treatment with
angiotensin-converting enzyme inhibitors + betablockers
should be considered as a prevention of further decrease
of LVEF
baseline risk assessment
LVEF should be determined before and periodically during the
treatment using the same method
Cardio-oncology Clinic
key components for the
effective work of the cardio-oncology centre
Experienced staff
CV testing
Appropriate location
High level of programme leadership